Switzerland - English
COMMITTED TO MAKING A DIFFERENCE
Novavax, Inc. is a global biotechnology company committed to helping address serious infectious diseases globally through the discovery, development, and delivery of innovative vaccines to patients around the world.
We never rest in our quest to protect the health of people everywhere.
Novavax is here to make a difference. We're a biotech company focused solely on developing life-saving vaccines to fight infectious diseases.
Our commitment is backed by solid science tested by decades of research, vaccines developed from trusted technology and a global network that will help to ensure our vaccines reach everyone who needs them.
Select local leaders
Head of DACH cluster,
Novavax in Europe
Novavax AB is located in Uppsala, Sweden. This facility is responsible for research, development and production of our saponin-based adjuvants. Our Matrix-MTM is used in multiple vaccine candidates to enhance the immune response and stimulate high levels of neutralizing antibodies.
In 2020, Novavax CZ, located in Bohumil, the Czech Republic was established. The facility is a state-of-the-art vaccine and biologics manufacturing campus dedicated to producing vaccines that help protect global health.
Starting 2022, Novavax started to develop commercial hubs throughout Europe with the regional main office in Zurich, Switzerland. Additional offices are now established also in Brussels, Belgium and Barcelona, Spain.
How to contact Novavax
09:00 - 17:00
Monday - Friday
More information is available on our global website, novavax.com.
Novavax CH GmbH
To contact a member of the investor relations team, click on the "Contact us" button below.